Sequester Travel: Halved FDA Budget Limits Opportunities For Scientists, Impacts Senior Officials Too
Executive Summary
Analysis of meetings in FDA’s public calendar indicates Commissioner Hamburg, other senior leaders continue to attend meetings throughout the U.S. and overseas; stakeholders worry sequester-induced travel cuts prevent rank-and-file scientists from attending helpful events.
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
FDA Scientists Give Leadership High Marks; Some Worry About Industry Influence
Union of Concerned Scientists' survey finds 65% of 354 respondents feel their direct supervisors back them on politically contentious positions; Commissioner Gottlieb gets glowing reviews.
US FDA Scientists Give Leadership High Marks, But Some Worry About Industry Influence
A Union of Concerned Scientists' survey finds 65% of 354 respondents believe their direct supervisors back them on politically contentious positions; US FDA Commissioner Scott Gottlieb gets glowing reviews.